{
  "metadata": {
    "title": "Source Quotes and References",
    "description": "Comprehensive collection of source quotes, citations, and references supporting all claims made throughout the War on Disease documentation.",
    "aliases": [
      "/references.html"
    ],
    "published": true,
    "tags": [
      "references",
      "sources",
      "citations",
      "quotes",
      "data",
      "research"
    ]
  },
  "references": [
    {
      "id": "fda-new-drug-approvals",
      "title": "Estimated deaths from FDA drug lag (1962-present)",
      "quotes": [
        "30–40 new drugs approved annually in the U.S. on average.",
        "Dale Gieringer (1985): 21,000-120,000 lives lost per decade from FDA delay",
        "Gieringer: \"Loss of life from delay alone in the hundreds of thousands\" (not millions)",
        "Beta-blockers alone: William Wardell estimated \"10,000 lives/year\" if allowed; FDA delay 1965-1976",
        "Sam Peltzman: Post-1962 death toll from regulatory delay \"easily number in thousands per year\"",
        "Practolol (beta-blocker): \"Could save 10,000 lives/year\" (Wardell estimate)",
        "FDA allowed propranolol 1968 (3 years after Europe); for hypertension/angina not until 1978",
        "Note: \"4-10 million\" figure not found in sources. Gieringer's estimates: 21K-120K deaths per decade, \"hundreds of thousands\" total (not millions). Specific drug delays (beta-blockers): ~100K deaths estimated"
      ],
      "sources": [
        {
          "text": "FDA, Novel Drug Approvals 2022",
          "url": "https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2022"
        },
        {
          "text": "FEE: Patients and Doctors vs FDA",
          "url": "https://fee.org/articles/patients-and-doctors-vs-the-fda"
        },
        {
          "text": "Econlib: Drug Lag",
          "url": "https://www.econlib.org/library/Enc/DrugLag.html"
        },
        {
          "text": "FDAReview.org: Theory, Evidence, Examples of FDA Harm",
          "url": "https://www.fdareview.org/issues/theory-evidence-and-examples-of-fda-harm/"
        }
      ]
    },
    {
      "id": "nih-funded-approved-drugs",
      "title": "Basic vs. Clinical Research Split (~54% vs ~33%)",
      "quotes": [
        "\"NIH funding contributed to published research associated with every one of the 356 new drugs approved by the FDA from 2010–2019.\" Total NIH spending on this research was $187 billion, while industry spending on clinical development for these drugs was significantly higher.",
        "Approximately 54% of the NIH research budget is devoted to basic biomedical and behavioral research, while about one-third (33%) is allocated to clinical research including patient-oriented research, clinical trials, and health services research. Categories overlap so totals exceed 100%."
      ],
      "sources": [
        {
          "text": "Bentley University / Cleary et al. (PNAS 2020)",
          "url": "https://www.pnas.org/doi/10.1073/pnas.1920929117"
        },
        {
          "text": "Mazzucato: The Entrepreneurial State",
          "url": "https://marianamazzucato.com/books/the-entrepreneurial-state"
        },
        {
          "text": "HHS, FY2016 Budget in Brief - NIH",
          "url": "https://www.hhs.gov/about/budget/budget-in-brief/nih/index.html"
        }
      ]
    }
  ]
}